T3D-959

T3D-959 · T3D Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for T3D-959, covering 2024-07-19 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects [Phase 2, Phase 3]

See pricing